Onyx ONE Clear Study - Keep Me Informed

Studying 1-month DAPT in high bleeding risk patients with Resolute Onyx^™ DES

DON’T MISS OUT ON THIS IMPORTANT STUDY

Simply fill out the short form below to receive email updates as results become available.

* Indicates a required field.

Send me DAPT clinical trial results when available.

Do you opt in to receive email messages from Medtronic?*

ABOUT THIS DROPDOWN:
Select "Yes" to confirm you’d like to receive our Value in Healthcare emails. Selecting "No" will result in no emails from us, the same as not signing up, but is a required option under data privacy laws. We value your privacy, and you may discontinue receiving emails at any time using the unsubscribe link at the bottom of all Medtronic emails.

Your information will be collected and processed in accordance with our Privacy Statement.

©2018 Medtronic. All rights reserved. Medtronic, Medtronic logo, and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. For distribution in the USA only.